Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
2.010
0.00 (0.00%)
At close: Dec 31, 2025, 4:00 PM EST
2.100
+0.090 (4.48%)
Pre-market: Jan 2, 2026, 5:50 AM EST
Opus Genetics Market Cap
Opus Genetics has a market cap or net worth of $138.62 million as of January 2, 2026. Its market cap has increased by 330.49% in one year.
Market Cap
138.62M
Enterprise Value
108.87M
1-Year Change
330.49%
Ranking
Category
Stock Price
$2.01
Market Cap Chart
Since November 6, 2020, Opus Genetics's market cap has increased from $21.26M to $138.62M, an increase of 551.94%. That is a compound annual growth rate of 43.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 138.62M | 268.99% |
| Dec 31, 2024 | 37.57M | -44.87% |
| Dec 29, 2023 | 68.14M | -7.23% |
| Dec 30, 2022 | 73.45M | 13.82% |
| Dec 31, 2021 | 64.53M | -8.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 966.79B |
| Johnson & Johnson | 498.51B |
| AbbVie | 406.04B |
| UnitedHealth Group | 300.88B |
| AstraZeneca | 287.28B |
| Novartis AG | 266.00B |
| Merck & Co. | 263.24B |
| Novo Nordisk | 227.63B |